Other languages Shield Therapeutics plc

Equities

Market Closed - London S.E. Other stock markets 08:59:32 01/05/2024 pm IST			5-day change	1st Jan Change
1.744 ^GBX	+29.19%		+22.39%	-73.97%

30/04	EARNINGS AND TRADING: Software Circle & Beximco report higher revenue	AN
22/02	Transcript : Shield Therapeutics plc, 2023 Sales/ Trading Statement Call, Feb 22, 2024

FTSE 100 takes hit ahead of FOMC minutes	21/02
Shield Therapeutics sinks as strong performance marred by data issues	21/02
Shield Therapeutics hires former Akili leader as new CFO	09/01
Shield Therapeutics Names New CFO	09/01
Comptoir opens restaurant; Intercede wins contract	07/12
Shield Therapeutics Chief Financial Officer Rudolf to leave	12/23/12
AIM WINNERS & LOSERS: Windward sees high contracting activity levels	12/23/12
Shield Therapeutics CFO to Step Down	12/23/12
Aston Martin CEO ups stake; Alkemy's lithium deal	03/23/03
Shield Therapeutics completes USD20 million SWK financing	03/23/03
Shield Therapeutics Closes $20 Million Debt Facility with SWK Funding	03/23/03
EARNINGS AND TRADING: Kingswood cuts outlook; Poolbeg in patent joy	02/23/02
Shield Therapeutics Raises $6 Million via Share Issue	29/23/29
Shield Therapeutics completes GBP5 million share placing	28/23/28
Shield Therapeutics raises funds for US sales push as loss narrows	28/23/28
Earnings Flash (STX.L) SHIELD THERAPEUTICS Posts H1 Revenue $4.3M	28/23/28
Shield Therapeutics plc Reports Earnings Results for the Half Year Ended June 30, 2023	28/23/28
Shield Therapeutics changes reporting currency to US dollars	07/23/07
Shield Therapeutics prescription orders up in first quarter	20/23/20
Shield Therapeutics plc Auditor Raises 'Going Concern' Doubt	19/23/19

No results for this search